245 related articles for article (PubMed ID: 33038448)
1. Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice.
McSweeney MD; Shen L; DeWalle AC; Joiner JB; Ciociola EC; Raghuwanshi D; Macauley MS; Lai SK
J Control Release; 2021 Jan; 329():774-781. PubMed ID: 33038448
[TBL] [Abstract][Full Text] [Related]
2. Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG.
McSweeney MD; Price LSL; Wessler T; Ciociola EC; Herity LB; Piscitelli JA; DeWalle AC; Harris TN; Chan AKP; Saw RS; Hu P; Jennette JC; Forest MG; Cao Y; Montgomery SA; Zamboni WC; Lai SK
J Control Release; 2019 Oct; 311-312():138-146. PubMed ID: 31454530
[TBL] [Abstract][Full Text] [Related]
3. Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine.
Shen L; Li Z; Ma A; Cruz-Teran C; Talkington A; Shipley ST; Lai SK
ACS Nano; 2024 Mar; 18(12):8733-8744. PubMed ID: 38469811
[TBL] [Abstract][Full Text] [Related]
4. Pegloticase co-administered with high MW polyethylene glycol effectively reduces PEG-immunogenicity and restores prolonged circulation in mouse.
Li Z; Shen L; Ma A; Talkington A; Li Z; Nyborg AC; Bowers MS; LaMoreaux B; Livingston EW; Frank JE; Yuan H; Lai SK
Acta Biomater; 2023 Oct; 170():250-259. PubMed ID: 37659730
[TBL] [Abstract][Full Text] [Related]
5. A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse.
McSweeney MD; Wessler T; Price LSL; Ciociola EC; Herity LB; Piscitelli JA; Zamboni WC; Forest MG; Cao Y; Lai SK
J Control Release; 2018 Aug; 284():171-178. PubMed ID: 29879519
[TBL] [Abstract][Full Text] [Related]
6. A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes.
Talkington AM; McSweeney MD; Wessler T; Rath MK; Li Z; Zhang T; Yuan H; Frank JE; Forest MG; Cao Y; Lai SK
J Control Release; 2022 Mar; 343():518-527. PubMed ID: 35066099
[TBL] [Abstract][Full Text] [Related]
7. Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives.
Gaballa SA; Shimizu T; Ando H; Takata H; Emam SE; Ramadan E; Naguib YW; Mady FM; Khaled KA; Ishida T
J Pharm Sci; 2024 Mar; 113(3):555-578. PubMed ID: 37931786
[TBL] [Abstract][Full Text] [Related]
8. Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture.
Lin YC; Chen BM; Tran TTM; Chang TC; Al-Qaisi TS; Roffler SR
J Control Release; 2023 Feb; 354():354-367. PubMed ID: 36641121
[TBL] [Abstract][Full Text] [Related]
9. Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice.
Gaballa SA; Shimizu T; Takata H; Ando H; Ibrahim M; Emam SE; Amorim Matsuo NC; Kim Y; Naguib YW; Mady FM; Khaled KA; Ishida T
Mol Pharm; 2024 Feb; 21(2):622-632. PubMed ID: 38273445
[TBL] [Abstract][Full Text] [Related]
10. [Induction of Anti-PEG Immune Responses by PEGylation of Proteins].
Shimizu T; Ishima Y; Ishida T
Yakugaku Zasshi; 2020; 140(2):163-169. PubMed ID: 32009039
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies.
Chen BM; Cheng TL; Roffler SR
ACS Nano; 2021 Sep; 15(9):14022-14048. PubMed ID: 34469112
[TBL] [Abstract][Full Text] [Related]
12. A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes.
El Sayed MM; Shimizu T; Abu Lila AS; Elsadek NE; Emam SE; Alaaeldin E; Kamal A; Sarhan HA; Ando H; Ishima Y; Ishida T
Int J Pharm; 2022 Mar; 615():121539. PubMed ID: 35124114
[TBL] [Abstract][Full Text] [Related]
13. Detection of Pre-Existing Antibodies to Polyethylene Glycol and PEGylated Liposomes in Human Serum.
Neun BW; Dobrovolskaia MA
Methods Mol Biol; 2024; 2789():185-192. PubMed ID: 38507004
[TBL] [Abstract][Full Text] [Related]
14. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
Subasic CN; Butcher NJ; Minchin RF; Kaminskas LM
Mol Pharm; 2023 Jul; 20(7):3494-3504. PubMed ID: 37256791
[TBL] [Abstract][Full Text] [Related]
15. Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route.
Takata H; Shimizu T; Yamade R; Elsadek NE; Emam SE; Ando H; Ishima Y; Ishida T
J Control Release; 2023 Aug; 360():285-292. PubMed ID: 37355210
[TBL] [Abstract][Full Text] [Related]
16. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
Shimizu T; Abu Lila AS; Fujita R; Awata M; Kawanishi M; Hashimoto Y; Okuhira K; Ishima Y; Ishida T
Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
[TBL] [Abstract][Full Text] [Related]
17. High MW polyethylene glycol prolongs circulation of pegloticase in mice with anti-PEG antibodies.
Talkington AM; McSweeney MD; Zhang T; Li Z; Nyborg AC; LaMoreaux B; Livingston EW; Frank JE; Yuan H; Lai SK
J Control Release; 2021 Oct; 338():804-812. PubMed ID: 34481925
[TBL] [Abstract][Full Text] [Related]
18. Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.
Elsadek NE; Emam SE; Abu Lila AS; Shimizu T; Ando H; Ishima Y; Ishida T
Biol Pharm Bull; 2020; 43(9):1393-1397. PubMed ID: 32879214
[TBL] [Abstract][Full Text] [Related]
19. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
[TBL] [Abstract][Full Text] [Related]
20. Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients.
Miao G; He Y; Lai K; Zhao Y; He P; Tan G; Wang X
J Control Release; 2023 Nov; 363():12-26. PubMed ID: 37717659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
